CTB
GPCR icon

Country Trust Bank’s Structure Therapeutics GPCR Stock Holding History

Country Trust Bank’s Portfolio GPCR Stock Details GPCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-500
Closed -$34.8K – 606
2025
Q4 		$34.8K Hold
500
– – ﹤0.01% 212
2025
Q3 		$14K Hold
500
– – ﹤0.01% 296
2025
Q2 		$10.4K Buy
+500
New +$11K ﹤0.01% 304

Other funds holding GPCR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

Country Trust Bank's GPCR Position: Q1 2026 in Review

Country Trust Bank sold out of Structure Therapeutics (GPCR) in Q1 2026, closing a stake of 500 shares — an estimated $34.8K sold.

Country Trust Bank first reported a position in GPCR in Q2 2025 and held it in 3 quarters. The position peaked at $34.8K in Q4 2025. 196 funds tracked by Wall St. Rank hold GPCR as of Q1 2026.

  • Country Trust Bank reported no remaining Structure Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Country Trust Bank sold 500 Structure Therapeutics shares in Q1 2026, an estimated $34.8K.
  • Country Trust Bank first reported a position in Structure Therapeutics in Q2 2025 and held it in 3 quarters.
  • Country Trust Bank's Structure Therapeutics position peaked at $34.8K in Q4 2025.
  • 196 funds tracked by Wall St. Rank held Structure Therapeutics as of Q1 2026.

Based on Country Trust Bank's 13F filing for Q1 2026, filed 10 Apr 2026.